Inventor

Adrien Tak Li

Inventor
Fontenay aux Roses, FR

Overview

14→
Patents
2005–2015
Patent span
Human necessities
Primary field (CPC A)

Patents· 14 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes16%
C07CAcyclic or carbocyclic compounds11%
PatentTitleYear
9,108,971'6-cycloamino-3-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof'20158,846,676'6-cycloamino-3-(pyrid-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof'20148,455,491'6-cycloamino-3-(pyridazin-4-yl)imidazo[1,2-b]pyridazine and derivatives and pharmaceutical compositions comprising the same'20138,354,405'6-cycloamino-3-(pyrid-4-yl)imidazo[1,2-b]pyridazine derivatives, preparation thereof and therapeutic use thereof'20138,119,687'Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics'20128,114,866'Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the FAAH enzyme'20127,777,057'Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics'20107,687,503'Derivatives of 1-piperazine-and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the FAAH enzyme'20107,566,720'2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a] pyrimidin-5(1H)one derivatives'20097,476,756'Alkyl-, alkenyl- and alkynylcarbamate derivatives, their preparation and their application in therapeutics'20097,378,413'2-amino-3-(alkyl)-pyrimidone derivatives'20087,119,116'Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics'20066,974,819'2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydoimidazo{1,2-a}pyrimidin-5(1H)one derivatives'20056,844,335'2-amino-3-(alkyl)-pyrimidone derivatives as GSK3.β.inhibitors'2005

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2005–2009Patents assigned to MITSUBISHI PHARMA CORP (4)· patent assignee history
2005–2015Based in Fontenay aux Roses, FR· patent location history
2006–2012Patents assigned to SANOFI AVENTIS (8)· patent assignee history
2012–2014Patents assigned to LI ADRIEN TAK (5)· patent assignee history
2013–2015Patents assigned to SANOFI SA (4)· patent assignee history
2013–2014Patents assigned to BURNIER PHILIPPE (3)· patent assignee history
2013Based in Bridgewater, NJ, US· patent location history
2013Based in Paris, FR· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SANOFI AVENTIS82006–2012
LI ADRIEN TAKself52012–2014
MITSUBISHI PHARMA CORP42005–2009
SANOFI SA42013–2015
BURNIER PHILIPPE32013–2014
Locations
LocationPatentsSpan
Fontenay aux Roses, FR122005–2015
Bridgewater, New Jersey, US12013
Paris, FR12013